Research status on the treatment of refractory epilepsy in children by Cannabidiol as adjunctive therapy
10.3760/cma.j.issn.2095-428X.2019.24.020
- VernacularTitle: 大麻二酚添加治疗儿童难治性癫痫的研究现状
- Author:
Dandan MAO
1
;
Wenguang HU
Author Information
1. Department of Pediatric Neurology, Chengdu Women′s and Children′s Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 611731, China
- Publication Type:Review
- Keywords:
Refractory epilepsy;
Cannabidiol;
Research status;
Child
- From:
Chinese Journal of Applied Clinical Pediatrics
2019;34(24):1914-1916
- CountryChina
- Language:Chinese
-
Abstract:
In the past 20 years, new anti-epileptic drugs have been constantly developed, but the percentages of patients who suffer from refractory epilepsy have not been significantly decreased.Therefore, to find out a drug that can effectively reduce seizures with relatively fewer side effects has become an urgent issue.In recent years, the treatment of epilepsy based on Cannabis has drawn great public attention.Cannabidiol, which is purified from Cannabis, can relieve refractory epilepsy in children.The present findings of research are summarized in this paper.
